Harry has posted Charts of the Day video on CYNO at TheTechTrader site noting: Cynosure, Inc. (CYNO) is acting well. After the pop, breakout, and then the pullback consolidation for about four weeks, it popped one more time, got up to the resistance, and stalled. Wednesday was a big day, up 2.41 to 52.65, or 4.8%, on 550,000 shares traded. That’s the second biggest volume on an up-day in about two months. I'm looking for a target of 55, and then 59 next on this stock.

$CYNO recent news/filings

bullish 43.99

## source: finance.yahoo.com

Tue, 08 Dec 2015 18:17:13 GMT ~ CYNOSURE INC Financials


read full: http://finance.yahoo.com/q/is?s=cyno
*********************************************************

Mon, 30 Nov 2015 08:00:26 GMT ~ Hedge Funds Are Crazy About Cynosure, Inc. (CYNO)


read full: http://www.insidermonkey.com/blog/hedge-funds-are-crazy-about-cynosure-inc-cyno-394189/
*********************************************************

Mon, 23 Nov 2015 18:05:17 GMT ~ Is CVR Partners LP (UAN) A Good Stock To Buy?


read full: http://www.insidermonkey.com/blog/is-cvr-partners-lp-uan-a-good-stock-to-buy-386224/
*********************************************************

Mon, 09 Nov 2015 13:56:08 GMT ~ Cynosure to Participate in Upcoming Investor Conferences

[at noodls] - Cynosure to Participate in Upcoming Investor Conferences

read full: http://www.noodls.com/view/FB76540F8D721DB04C5792B47DA6BB181AD323E2
*********************************************************

Mon, 09 Nov 2015 13:30:00 GMT ~ Cynosure to Participate in Upcoming Investor Conferences

[PR Newswire] - WESTFORD, Mass., Nov. 9, 2015 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications, today announced ...

read full: http://finance.yahoo.com/news/cynosure-participate-upcoming-investor-conferences-133000369.html
*********************************************************

$CYNO charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$CYNO company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/CYNO/company-info
Ticker: $CYNO
OTC Market Place: Not Available
CIK code: 0000885306
Company name: Cynosure, Inc.
Incorporated In: DE, USA

$CYNO share structure

## source: otcmarkets.com

Market Value: $999,703,895 a/o Dec 24, 2015
Shares Outstanding: 22,725,708 a/o Oct 29, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001

$CYNO extra dd links

Company name: Cynosure, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CYNO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CYNO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CYNO+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CYNO/news - http://finance.yahoo.com/q/h?s=CYNO+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CYNO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CYNO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CYNO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CYNO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Cynosure%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Cynosure%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Cynosure%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CYNO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000885306&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CYNO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CYNO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CYNO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CYNO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CYNO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CYNO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CYNO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CYNO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CYNO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CYNO+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CYNO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CYNO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CYNO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CYNO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CYNO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CYNO/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CYNO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CYNO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CYNO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CYNO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CYNO



$CYNO DD Notes ~ http://www.ddnotesmaker.com/CYNO

Cynosure Reports Record Quarterly Revenue of $86.3 Million for the Fourth Quarter of 2014
1 hours 35 minutes ago - DJNF
WESTFORD, Mass., Feb. 10, 2015 /PRNewswire/ -- Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today reported financial results for the three and 12 months ended December 31, 2014.
Financial Highlights

-- Q4 revenue up 16 percent year-over-year to $86.3 million

-- Q4 GAAP net income of $23.0 million, or $1.05 per diluted share,

reflecting the release of income tax valuation allowance

-- Q4 non-GAAP net income of $7.9 million, or $0.36 per diluted share,

excluding the release of income tax valuation allowance, acquisition

costs and amortization expenses

-- Q4 cash from operations of $22.2 million; $133.4 million in cash and

investments at December 31, 2014

-- Full-year 2014 revenue of $292.4 million, up 29 percent

"We capped an outstanding year in 2014 with a solid fourth quarter, driven by record revenues and continued profitability," said Cynosure Chairman and Chief Executive Officer Michael Davin. "Equally important, we continue to generate strong operating cash flow and strengthen our balance sheet, while at the same time stepping up R&D and marketing investments as we focus on accelerating the pace at which our products are coming to market."

"For example, we recently submitted, two months ahead of our original schedule, the 510(k) premarket notification to the U.S. Food and Drug Administration for our newest flagship technology, a 1060 nm laser for the non-invasive reduction of fat, with a goal of introducing the product in the second half of 2015," Davin said. "We have expanded our engineering team and are investing in other product development initiatives. To address growing demand and new markets, we continue to broaden our distribution network, entering 2015 with the largest North American direct field sales force in the Company's history. To serve physicians in the women's health market, we are adding a 13-person specialty sales force to market MonaLisa Touch(TM) in North America."

Management's Comments on 2014

"Demand for our flagship picosecond laser, PicoSure(R) , remains a key driver of our North American laser business, which was up 29 percent in the fourth quarter of 2014 from the fourth quarter of 2013," Davin said. "PicoSure has become the gold standard for tattoo removal and benign pigmented lesions since its U.S. introduction less than two years ago. Over the past two quarters we have seen increasing orders for PicoSure's disposable FOCUS lens array, spurred by recent regulatory clearances for the treatment of wrinkles and acne scarring. We expect to introduce a 532 nm wavelength laser delivery system for PicoSure at the annual meeting of the American Academy of Dermatology in March which will be upgradable to the installed base. We also expect to introduce a third wavelength delivery system for PicoSure in the second half of the year. Internationally, our Asian subsidiaries and third-party distributors contributed to our top-line growth in the quarter, partly reflecting the addition of the new radiofrequency surgical assets we acquired from Ellman International in the third quarter."

"The Ellman transaction is just one of several major accomplishments for Cynosure in 2014, a year of growth, expansion and diversification," Davin said. "We completed the integration of Palomar Medical Technologies, an acquisition that helped us become one of the world's premier energy-based aesthetic companies. We secured new international regulatory clearances for certain of our products, including PicoSure and Smartlipo Triplex. We introduced MonaLisa Touch, a carbon dioxide (CO2) laser for the treatment of vaginal atrophy, a condition that affects primarily postmenopausal women, breast cancer survivors and women who have undergone hysterectomies. In addition, we demonstrated continued scientific leadership with 35 clinical research presentations at the American Society for Laser Medicine and Surgery Annual Conference."

Results for the Three Months Ended December 31, 2014

Total revenues for the fourth quarter of 2014 were $86.3 million, an increase of 16 percent compared with $74.5 million for the fourth quarter of 2013.

Net income for the fourth quarter of 2014 was $23.0 million, or $1.05 per diluted share, compared with net income of $7.3 million, or $0.33 per diluted share, for the fourth quarter of 2013. Net income for the fourth quarter of 2014 included an income tax benefit of $19.6 million, or $0.89 per diluted share, resulting from the release of the income tax valuation allowance relating to net deferred tax assets.

On a non-GAAP basis, excluding the income tax benefit relating to the release of the income tax valuation allowance, acquisition costs and amortization, fourth-quarter 2014 net income was $7.9 million, or $0.36 per diluted share, compared with non-GAAP net income of $9.2 million, or $0.41 per diluted share, in the same period of 2013.

Cynosure had $133.4 million in cash and investments at December 31, 2014, compared with $113 million at the end of the third quarter of 2014 and $129 million at year-end 2013.

Recent Highlights

-- Submission of 510(k) for Non-Invasive Fat Reduction: Cynosure has

submitted to the U.S. Food and Drug Administration a 510(k) application

to market its newest flagship product, a 1060 nm laser for the

non-invasive reduction of fat. The application is supported by clinical

data from approximately 100 patients treated with the device at two U.S.

sites.

-- Exclusive Agreement to Market MonaLisa Touch: Cynosure signed an

exclusive agreement with El.En. S.p.A. to market and distribute in North

America the MonaLisa Touch, a carbon dioxide (CO2) laser for the

treatment of vaginal atrophy, a condition that affects primarily

postmenopausal women, breast cancer survivors and women who have

undergone hysterectomies. Cynosure launched the MonaLisa Touch in

January.

-- Favorable Clinical Data: A multi-center trial showed a statistically

significant improvement in the vaginal health of women treated with the

MonaLisa Touch. The multicenter trial assessed the use of CO2 fractional

laser therapy on 30 women with menopause-related symptoms such as dryness,

pain, itching, painful urination and painful intercourse. Preliminary

trial data was presented in December at the 2014 Pelvic Anatomy and

Gynecologic Surgery Symposium.

Business Outlook

"We achieved 29 percent revenue growth and solid profitability in 2014 by successfully executing on our strategy of organic growth, complementary acquisitions and prudent balance sheet management," Davin said. "Today, we are financially and operationally stronger than at any point in our history. With the rollout of MonaLisa Touch and the planned introduction of our new non-invasive technology for fat removal in the second half of this year, we believe we are well positioned for momentum in 2015 and beyond."

Fourth-Quarter Financial Results Conference Call

In conjunction with the announcement of its fourth-quarter and year-end 2014 financial results, Cynosure will host a conference call for investors and analysts at 9:00 a.m. ET today. On the call, Chairman and CEO Michael Davin and Timothy Baker, the Company's President and Chief Financial Officer, will discuss Cynosure's financial results and provide a business overview. Those who wish to listen to the conference call webcast should visit the "Investors" section of the Company's website at www.cynosure.com. The live call can also be accessed by dialing (877) 709-8155 or (201) 689-8881. If you are unable to listen to the live call, the webcast will be archived for one year on the Company's website.

About Cynosure, Inc.

Cynosure develops, manufactures, and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve vaginal health. Cynosure also markets radiofrequency energy sourced medical devices for precision surgical applications such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. Cynosure's product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, Q-switched lasers, intense pulsed light and radiofrequency technology. Cynosure sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names through a direct sales force in the United States, Canada, Mexico, France, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 120 other countries. For corporate or product information, visit Cynosure's website at www.cynosure.com.

Forward-Looking Statements

(MORE TO FOLLOW) Dow Jones Newswires

February 10, 2015 08:00 ET (13:00 GMT)

Cynosure Reports Record Third-Quarter Revenue of $71.5 Million, Up 18% Year-Over-Year
3 hours 54 minutes ago - DJNF
WESTFORD, Mass., Oct. 28, 2014 /PRNewswire/ -- Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today reported financial results for the three months ended September 30, 2014.

Third-Quarter 2014 Highlights

-- Revenue up 18% year-over-year to $71.5 million

-- Non-GAAP net income of $5.5 million, or $0.25 per diluted share,

excluding amortization expenses, acquisition costs and unrealized

foreign exchange loss

-- GAAP net income of $3.1 million, or $0.14 per diluted share, including

amortization expenses, acquisition costs and unrealized foreign exchange

loss

-- $113 million in cash and investments at September 30, 2014

-- Repurchased $6.6 million of common stock under share repurchase program

-- Acquired assets of RF medical device manufacturer Ellman International,

Inc.

"Cynosure delivered record third-quarter revenue of $71.5 million, up 18 percent year-over-year as revenue in each of our direct sales channels improved from the same period in 2013," said Cynosure Chairman and Chief Executive Officer Michael Davin. "North American laser revenue increased 17 percent, revenue from our Asia Pacific subsidiaries rose 46 percent, while our European direct sales channel was up 7 percent. Product and technology innovation, expanded indications and new international marketing clearances continue to drive favorable results for the Company."

"Demand for our flagship PicoSure(R) Picosecond Laser Workstation continues to exceed our expectations," Davin continued. "Based on enthusiastic customer feedback and patient and physician satisfaction, we believe this technology is becoming the gold standard for the removal of tattoos and benign pigmented lesions. New FDA marketing clearances, combined with recent international regulatory approvals in Korea, Taiwan and Australia, demonstrate the successful execution of our strategy to drive growth for PicoSure worldwide."

Recent Highlights

-- Ellman International, Inc. Acquisition. During the third quarter,

Cynosure announced that it acquired the assets of Ellman International,

Inc. for approximately $13.2 million in cash. Based in Hicksville, NY,

Ellman develops, manufactures and markets advanced radiofrequency (RF)

technology for precision surgical and aesthetic procedures and offers a

line of aesthetic lasers.

-- PicoSure System Receives FDA Clearance for New Indications. The Company

received clearance from the U.S. Food and Drug Administration to market

the PicoSure system, previously approved for the removal of tattoos and

benign pigmented lesions, for the additional indications of acne scarring

as well as the treatment of fine lines and wrinkles.

-- Share Repurchase Program. During the third quarter, the Company

repurchased $6.6 million of common stock under its $35 million share

repurchase program. Approximately $4 million remained available under the

program at September 30, 2014.

"We ended the third quarter of 2014 with cash and investments of $113 million and generated cash from operations of $14.1 million during the quarter," Davin said. "We continued to effectively maintain our balance sheet strength while returning capital to our stockholders and investing to profitably grow the business."

Business Outlook

"Looking ahead, Cynosure is well-positioned to deliver top-line growth and increased profitability," Davin said. "Our healthy, unencumbered balance sheet supports our strategy to drive growth organically and through strategic acquisitions. We are on schedule to launch our next flagship platform in 2015 for non-invasive fat removal, and we believe this large addressable market represents a significant growth opportunity for the Company."

Third-Quarter Financial Results Conference Call

In conjunction with the announcement of its third-quarter 2014 financial results, Cynosure will host a conference call for investors and analysts at 9:00 a.m. ET today. On the call, Michael Davin and Timothy Baker, the Company's President and Chief Financial Officer, will discuss Cynosure's financial results and provide a business overview. Those who wish to listen to the conference call webcast should visit the "Investors" section of the Company's website at www.cynosure.com. The live call can also be accessed by dialing (877) 709-8155 or (201) 689-8881. If you are unable to listen to the live call, the webcast will be archived for one year on the Company's website.

About Cynosure, Inc.

Cynosure designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus and ablate sweat glands. Cynosure's product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, Q-switched lasers, intense pulsed light and radiofrequency technology. Cynosure sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names through a direct sales force in the United States, Canada, Mexico, France, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 120 other countries. For corporate or product information, visit Cynosure's website at www.cynosure.com.

Forward-Looking Statements

Any statements in this press release about future expectations, plans and prospects for Cynosure, Inc., including Cynosure's intention to repurchase shares of its common stock from time to time under the share repurchase program, Cynosure's intention to broaden its reach through expanded indications and marketing programs, research and development projects, and Cynosure's active pipeline of potential acquisition opportunities, as well as other statements containing the words "believes," "anticipates," "plans," "expects," "will" and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the market price of Cynosure's stock prevailing from time to time, the nature of other investment opportunities presented to the Company from time to time, the Company's cash flows from operations, levels of demand for procedures performed with Cynosure products and for Cynosure products themselves, competition in the aesthetic laser industry, general business and economic conditions, effects of acquisitions that Cynosure has made or may make, Cynosure's ability to develop and commercialize new products, Cynosure's reliance on sole source suppliers, the inability to accurately predict the timing or outcome of regulatory decisions, and economic, market, technological and other factors discussed in Cynosure's most recent Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q for the first and second quarters of 2014, which are filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent Cynosure's views as of the date of this press release. Cynosure anticipates that subsequent events and developments will cause its views to change. However, although Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Cynosure's views as of any date subsequent to the date of this press release.

Contact:

Timothy Baker Scott Solomon

President and Chief Financial Officer Vice President

Cynosure, Inc. Sharon Merrill Associates

(978) 256-4200 (617) 542-5300

TBaker@cynosure.com CYNO@investorrelations.com

Consolidated Statements of Income (Unaudited)

---------------------------------------------------------------------------------------

(In thousands, except per share data)

Three Months Ended September 30, Nine Months Ended September 30,

2014 2013 2014 2013

-------------- ---------------- --------------- ------------------

Revenues $ 71,530 $ 60,692 $ 206,107 $ 151,473

Cost of revenues 31,232 26,558 89,721 65,865

-------------- ---------------- --------------- ------------------

Gross profit 40,298 34,134 116,386 85,608

Operating

expenses

Selling and

marketing 21,721 17,364 62,710 44,198

Research and

development 5,746 5,033 16,319 12,350

Amortization of

intangible

assets

acquired 740 451 2,166 948

General and

administrative 6,841 12,712 22,197 42,189

-------------- ---------------- --------------- ------------------

Total operating

expenses 35,048 35,560 103,392 99,685

Income (loss)

from

operations 5,250 (1,426) 12,994 (14,077)

Interest

(expense)

income, net (342) 25 (1,034) 80

Other (expense)

(MORE TO FOLLOW) Dow Jones Newswires

October 28, 2014 08:00 ET (12:00 GMT)

The FDA triple Play
How to Make 400% or More on Companies Curing
Tattoo Regret and Other Ugly Cosmetic Conditions

Cynosure, Inc.
(CYNO) has developed a new kind of laser removal
technology that’s far more effective, faster, and less painful than
conventional treatments.
It’s cheaper, too!
How does it accomplish this feat?
Well, it all comes down to laser technology...
Standard lasers, called Q-switched lasers, deliver heat to targeted areas in
nanoseconds – or billionths of a second.
But this new laser delivers ultra-short bursts of energy to the skin in
trillionths
of a second.
This process shoots enough energy to the targeted area that it actually
pulverizes the ink molecules into particles tiny enough that the body can
eliminate them as waste.
International health agencies recognize this, and they’re allowing Cynosure
to make its breakthrough available throughout the world.
Better yet, the technology has proven useful beyond unwanted tattoos. It’s
also making headway in other cosmetic industries, including liposuction,
cellulite treatment, and wrinkle removal.

Cynosure Announces Successful Settlement of Patent Infringement Lawsuits Against Tria Beauty







Print


Alert



Cynosure (NASDAQ:CYNO)
Intraday Stock Chart

Today : Monday 16 December 2013
Click Here for more Cynosure Charts.

WESTFORD, Mass., Dec. 16, 2013 /PRNewswire/ -- Cynosure, Inc. (Nasdaq:CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications, today announced that it will receive $10 million plus future royalty payments under a comprehensive settlement agreement with Tria Beauty, Inc. that ends the patent infringement litigation between Tria and Palomar Medical Technologies, which Cynosure acquired in June 2013.

"This agreement resolves the litigation involving certain Palomar patents, eliminating potential future legal expense to enforce those patents," said Michael R. Davin, Cynosure's President and CEO. "Equally important, the settlement fully values our intellectual property rights by fairly compensating Cynosure and its shareholders for sales of products based on our proprietary hair-removal technology."

The settlement includes two non-exclusive patent license agreements between Cynosure and Tria:
•The first agreement grants Tria a non-exclusive, worldwide license to U.S. Patent Nos. 5,735,844 and 5,595,568 and foreign counterparts for consumer hair removal products. These patents were acquired from Palomar by Cynosure. As part of the agreement, Tria will pay Cynosure $8.5 million. The first payment of $3.4 million is to be made by December 20, 2013. The second payment of $5.1 million is to be made on the earlier of September 15, 2014 or five business days following an initial public offering by Tria or a change of control of Tria. In addition, Cynosure will receive a royalty-free license to certain Tria patents outside the consumer field.
•The second agreement grants Tria a non-exclusive, royalty bearing, worldwide license to the claims of certain Palomar patents, including but not limited to U.S. Patent Nos. 8,182,473, 8,328,794, and 8,328,796, for consumer hair removal products. These patent claims cover the hair removal products that were the subject of the second lawsuit between Palomar and Tria. As part of the agreement, Tria will pay Cynosure $1.5 million covering sales made prior to October 1, 2013. The first payment of $600,000 is to be made by December 20, 2013. The second payment of $900,000 is to be made on the earlier of December 20, 2014 or five business days following an initial public offering by Tria or a change of control of Tria. In addition, Cynosure will receive a 3% royalty on U.S. sales made after October 1, 2013 through September 30, 2021 with respect to U.S. Patent Nos. 8,182,473, 8,328,794, and 8,328,796 or through the expiration of any other licensed Palomar patent if such expiration is after September 30, 2021, unless the second agreement is terminated earlier.

About Cynosure, Inc.
Cynosure develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, treat toe fungus and ablate sweat glands. Cynosure's product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, and Q-switched lasers and intense pulsed light. Cynosure sells its products globally under the Cynosure, Palomar and ConBio brand names through a direct sales force in the United States, Canada, Mexico, France, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 100 other countries. For corporate or product information, visit Cynosure's website at www.cynosure.com.

Forward-Looking Statements
Any statements in this press release relating to the settlement agreement between the Company and Tria Beauty, Inc. constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors including risks related to, among other things, the amount of future payments the Company expects to receive in connection with its settlement of its patent litigation, the date through which such payments may be received by the Company, the Company's ability to avoid future legal expenses as a result of the settlement, and the enforceability of the Company's intellectual property as well as other factors discussed in Cynosure's most recent Annual Report on Form 10-K and subsequently filed Quarterly Report on Form 10-Q for the third quarter of 2013, which are filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent Cynosure's views as of the date of this press release. Cynosure anticipates that subsequent events and developments will cause its views to change. However, although Cynosure may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so.



Contact:






Patricia A. Davis

Scott Solomon


SVP, General Counsel & Secretary

Vice President


Cynosure, Inc.

Sharon Merrill Associates


(978) 256-4200

(617) 542-5300


pdavis@cynosure.com

CYNO@investorrelations.com


SOURCE Cynosure, Inc.

~ Tuesday! $CYNO ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!

~ $CYNO ~ Earnings expected on Tuesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=CYNO&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=CYNO&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=CYNO
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=CYNO#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=CYNO+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=CYNO
Finviz: http://finviz.com/quote.ashx?t=CYNO
~ BusyStock: http://busystock.com/i.php?s=CYNO&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=CYNO >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

<<< $CYNO Links! >>> ~ MAC's Quick DD Links without the charts.



Open these links (or the ones you desire) in background tabs
http://help.opera.com/Linux/9.52/en/keyboard.html
http://lifehacker.com/263940/force-links-to-open-in-the-background


PennyStockTweets ~ http://www.pennystocktweets.com/stocks/profile/CYNO


OTC Markets Company Info ~ http://www.otcmarkets.com/stock/CYNO/company-info
OTC Markets Charts ~ http://www.otcmarkets.com/stock/CYNO/chart
OTC Markets Quote ~ http://www.otcmarkets.com/stock/CYNO/quote
OTC Markets News ~ http://www.otcmarkets.com/stock/CYNO/news
OTC Markets Financials ~ http://www.otcmarkets.com/stock/CYNO/financials
OTC Markets Short Sales ~ http://www.otcmarkets.com/stock/CYNO/short-sales
OTC Markets Insider Disclosure ~ http://www.otcmarkets.com/stock/CYNO/insider-transactions
OTC Markets Research Reports ~ http://www.otcmarkets.com/stock/CYNO/research


Google Finance Summary ~ http://www.google.com/finance?q=CYNO
Google Finance News ~ http://www.google.com/finance/company_news?q=CYNO
Google Finance Option chain ~ http://www.google.com/finance/option_chain?q=CYNO
Google Finance Financials ~ http://www.google.com/finance?q=CYNO&fstype=ii#
Google Finance Historical prices Daily ~ http://www.google.com/finance/historical?q=CYNO
Google Finance Historical prices Weekly ~ http://www.google.com/finance/historical?q=CYNO&histperiod=weekly#


Y! < Company >
Y! Profile ~ http://finance.yahoo.com/q/pr?s=CYNO+Profile
Y! Key Stat's ~ http://finance.yahoo.com/q/ks?s=CYNO+Key+Statistics
Y! Headlines ~ http://finance.yahoo.com/q/h?s=CYNO+Headlines
Y! Summary ~ http://finance.yahoo.com/q?s=CYNO
Y! Historical Prices ~ http://finance.yahoo.com/q/hp?s=CYNO+Historical+Prices
Y! Order Book ~ http://finance.yahoo.com/q/ecn?s=CYNO+Order+Book
Y! Message Boards ~ http://messages.finance.yahoo.com/mb/CYNO
Y! Market Pulse ~ http://finance.yahoo.com/marketpulse/CYNO
Y! Technical Analysis ~ http://finance.yahoo.com/q/ta?s=CYNO+Basic+Tech.+Analysis
Y! < Analyst Coverage >
Y! Analyst Opinion ~ http://finance.yahoo.com/q/ao?s=CYNO+Analyst+Opinion
Y! Analyst Estimates ~ http://finance.yahoo.com/q/ae?s=CYNO+Analyst+Estimates
Y! Research Reports ~ http://finance.yahoo.com/q/rr?s=CYNO+Research+Reports
Y! Star Analysts ~ http://finance.yahoo.com/q/sa?s=CYNO+Star+Analysts
Y! < Ownership >
Y! Major Holders ~ http://finance.yahoo.com/q/mh?s=CYNO+Major+Holders
Y! Insider Transactions ~ http://finance.yahoo.com/q/it?s=CYNO+Insider+Transactions
Y! Insider Roster ~ http://finance.yahoo.com/q/ir?s=CYNO+Insider+Roster
Y! < Financials >
Y! Income Statement ~ http://finance.yahoo.com/q/is?s=CYNO+Income+Statement&annual
Y! Balance Sheet ~ http://finance.yahoo.com/q/bs?s=CYNO+Balance+Sheet&annual
Y! Cash Flow ~ http://finance.yahoo.com/q/cf?s=CYNO+Cash+Flow&annual


FINVIZ ~ http://finviz.com/quote.ashx?t=CYNO&ty=c&ta=0&p=d


Investorshub Trades ~ http://ih.advfn.com/p.php?pid=trades&symbol=CYNO
Investorshub Board Search ~ http://investorshub.advfn.com/boards/getboards.aspx?searchstr=CYNO
Investorshub PostStream ~ http://investorshub.advfn.com/boards/poststream.aspx?ticker=CYNO
Investorshub Messages ~ http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=CYNO
Investorshub Videos ~ http://ih.advfn.com/p.php?pid=ihvse&ihvqu=CYNO
Investorshub News ~ http://ih.advfn.com/p.php?pid=news&btn=s_ok&ctl00%24sb3%24tbq1=Get+Quote&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=CYNO&s_ok=OK&from_month=3&from_day=15&from_year=2012&order=desc&selsrc%5B%5D=prnca&selsrc%5B%5D=prnus&selsrc%5B%5D=zacks&selsrc%5B%5D=money2&selsrc%5B%5D=djn&selsrc%5B%5D=bw&selsrc%5B%5D=globe&selsrc%5B%5D=edgar&selsrc%5B%5D=mwus&force=1&last_ts=1331855999&p_n=1&p_count=&p_ts=1331794260


CandlestickChart ~ http://www.candlestickchart.com/cgi/chart.cgi?symbol=CYNO&exchange=US


Barchart Quote ~ http://barchart.com/quotes/stocks/CYNO?
Barchart Detailed Quote ~ http://barchart.com/detailedquote/stocks/CYNO
Barchart Options Quotes ~ http://barchart.com/options/stocks/CYNO
Barchart Technical Chart ~ http://barchart.com/charts/stocks/CYNO&style=technical
Barchart Interactive Chart ~ http://barchart.com/charts/stocks/CYNO&style=interactive
Barchart Technical Analysis ~ http://barchart.com/technicals/stocks/CYNO
Barchart Trader's Cheat Sheet ~ http://barchart.com/cheatsheet.php?sym=CYNO
Barchart Barchart Opinion ~ http://barchart.com/opinions/stocks/CYNO
Barchart Snapshot Opinion ~ http://barchart.com/snapopinion/stocks/CYNO
Barchart News Headlines ~ http://barchart.com/news/stocks/CYNO
Barchart Profile ~ http://barchart.com/profile//CYNO
Barchart Key Statistics ~ http://barchart.com/profile.php?sym=CYNO&view=key_statistics


OTC: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=CYNO&MarketTicker=OTC&TYP=S
NASDAQ: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=CYNO&MarketTicker=NASD&TYP=S
NYSE: American Bulls ~ http://www.americanbulls.com/StockPage.asp?CompanyTicker=CYNO&MarketTicker=NYSE&Typ=S


Marketwatch Profile ~ http://www.marketwatch.com/investing/stock/CYNO/profile
Marketwatch Analyst Estimates ~ http://www.marketwatch.com/investing/stock/CYNO/analystestimates
Marketwatch Historical Quotes ~ http://www.marketwatch.com/investing/stock/CYNO/historical
Marketwatch Financials ~ http://www.marketwatch.com/investing/stock/CYNO/financials
Marketwatch Overview ~ http://www.marketwatch.com/investing/stock/CYNO
Marketwatch SEC Filings ~ http://www.marketwatch.com/investing/stock/CYNO/secfilings
Marketwatch Picks ~ http://www.marketwatch.com/investing/stock/CYNO/picks
Marketwatch Hulbert ~ http://www.marketwatch.com/investing/stock/CYNO/hulbert
Marketwatch Insider Actions ~ http://www.marketwatch.com/investing/stock/CYNO/insideractions
Marketwatch Options ~ http://www.marketwatch.com/investing/stock/CYNO/options
Marketwatch Charts ~ http://www.marketwatch.com/investing/stock/CYNO/charts
Marketwatch News ~ http://bigcharts.marketwatch.com/news/symbolsearch/symbolnews.asp?news=markadv&symb=CYNO&sid=1795093&framed=False


The Lion ~ http://thelion.com/bin/aio_msg.cgi?cmd=search&msg=&si=1&tw=1&tt=1&rb=1&ih=1&fo=1&iv=1&yf=1&sa=1&fb=1&gg=1&symbol=CYNO


Search NYSE ~ http://www.nyse.com/about/listed/lcddata.html?ticker=CYNO


StockTA ~ http://www.stockta.com/cgi-bin/analysis.pl?symb=CYNO&num1=567&cobrand=&mode=stock


StockHouse ~ http://www.stockhouse.com/financialtools/sn_overview.aspx?qm_symbol=CYNO
StockHouse Delayed LII ~ http://www.stockhouse.com/financialtools/sn_level2.aspx?qm_page=46140&qm_symbol=CYNO


AlphaTrade ~ http://tools.alphatrade.com/index.php?t1=mc_quote_module&t2=mc_quote_module2&t3=historical&template=historical2html&sym=CYNO&client_id=2740&a_width=680&a_height=1000&language=english&showVol=1&chtype=8


Reuters ~ http://www.reuters.com/finance/stocks/companyOfficers?symbol=CYNO.PK&WTmodLOC=C4-Officers-5


StockWatch ~ http://www.stockwatch.com/Quote/Detail.aspx?symbol=CYNO®ion=U


Search NASDAQ ~ http://www.nasdaq.com/symbol/CYNO
NASDAQ Divy History ~ http://www.nasdaq.com/symbol/CYNO/dividend-history
NASDAQ Short Interest ~ http://www.nasdaq.com/symbol/CYNO/short-interest
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/CYNO/institutional-holdings
NASDAQ FlashQuotes ~ http://www.nasdaq.com/aspx/flashquotes.aspx?symbol=CYNO&selected=CYNO
NASDAQ InfoQuotes ~ http://www.nasdaq.com/aspx/infoquotes.aspx?symbol=CYNO&selected=CYNO
NASDAQ After Hours Quote ~ http://www.nasdaq.com/symbol/CYNO/after-hours
NASDAQ Pre-Market Quote ~ http://www.nasdaq.com/symbol/CYNO/premarket
NASDAQ Historical Quote ~ http://www.nasdaq.com/symbol/CYNO/historical
NASDAQ Option Chain ~ http://www.nasdaq.com/symbol/CYNO/option-chain
NASDAQ Company Headlines ~ http://www.nasdaq.com/symbol/CYNO/news-headlines
NASDAQ Press Releases ~ http://www.nasdaq.com/symbol/CYNO/news-headlines
NASDAQ Sentiment ~ http://www.nasdaq.com/symbol/CYNO/sentiment
NASDAQ Analyst Summary ~ http://www.nasdaq.com/symbol/CYNO/analyst-research
NASDAQ Guru Analysis~ http://www.nasdaq.com/symbol/CYNO/guru-analysis
NASDAQ Stock Report ~ http://www.nasdaq.com/symbol/CYNO/stock-report
NASDAQ Competitors ~ http://www.nasdaq.com/symbol/CYNO/competitors
NASDAQ Stock Consultant ~ http://www.nasdaq.com/symbol/CYNO/stock-consultant
NASDAQ Stock Comparison ~ http://www.nasdaq.com/symbol/CYNO/stock-comparison
NASDAQ Call Transcripts ~ http://www.nasdaq.com/symbol/CYNO/call-transcripts
NASDAQ Annual Reports ~ http://www.nasdaq.com/aspx/annualreport.aspx?symbol=CYNO&selected=CYNO
NASDAQ Financials ~ http://www.nasdaq.com/symbol/CYNO/financials
NASDAQ Revenue & Earnings Per Share (EPS) ~ http://www.nasdaq.com/symbol/CYNO/revenue-eps
NASDAQ SEC Filings ~ http://www.nasdaq.com/symbol/CYNO/sec-filings
NASDAQ Ownership Summary ~ http://www.nasdaq.com/symbol/CYNO/ownership-summary
NASDAQ Institutional Ownership ~ http://www.nasdaq.com/symbol/CYNO/institutional-holdings
NASDAQ (SEC Form 4) ~
--------- All Trades ~ http://www.nasdaq.com/symbol/CYNO/insider-trades
--------- Buys ~ http://www.nasdaq.com/symbol/CYNO/insider-trades/buys
--------- Sells ~ http://www.nasdaq.com/symbol/CYNO/insider-trades/sells


The Motley Fool ~ http://caps.fool.com/Ticker/CYNO.aspx
The Motley Fool Earnings/Growth ~ http://caps.fool.com/Ticker/CYNO/EarningsGrowthRates.aspx?source=itxsittst0000001
The Motley Fool Ratios ~ http://caps.fool.com/Ticker/CYNO/Ratios.aspx?source=itxsittst0000001
The Motley Fool Stats ~ http://caps.fool.com/Ticker/CYNO/Stats.aspx?source=icasittab0000006
The Motley Fool Historical ~ http://caps.fool.com/Ticker/CYNO/Historical.aspx?source=icasittab0000004
The Motley Fool Scorecard ~ http://caps.fool.com/Ticker/CYNO/Scorecard.aspx?source=icasittab0000003
The Motley Fool Statements ~ http://caps.fool.com/Ticker/CYNO/Statements.aspx?source=icasittab0000009


MSN Money ~ http://investing.money.msn.com/investments/stock-ratings?symbol=CYNO


YCharts ~ http://ycharts.com/companies/CYNO
YCharts Performance ~ http://ycharts.com/companies/CYNO/performance
YCharts Dashboard ~ http://ycharts.com/companies/CYNO/dashboard


InsideStocks Opinion ~ http://www.insidestocks.com/texpert.asp?sym=CYNO&code=XDAILY
InsideStocks Profile ~ http://www.insidestocks.com/profile.asp?sym=CYNO&code=XDAILY
InsideStocks Quote ~ http://www.insidestocks.com/quote.asp?sym=CYNO&code=XDAILY
InsideStocks Projection ~ http://charts3.barchart.com/procal.asp?sym=CYNO


Zacks Quote ~ http://www.zacks.com/stock/quote/CYNO
Zacks Estimates ~ http://www.zacks.com/research/report.php?type=estimates&t=CYNO
Zacks Company Reports ~ http://www.zacks.com/research/report.php?type=report&t=CYNO


Knobias ~ http://knobias.10kwizard.com/files.php?sym=CYNO


StockScores ~ http://www.stockscores.com/quickreport.asp?ticker=CYNO


Trade-Ideas ~ http://www.trade-ideas.com/StockInfo/CYNO/HOT_TOPIC.html


Morningstar ~ http://performance.morningstar.com/stock/performance-return.action?region=USA&t=CYNO&culture=en-US
Morningstar Shareholders ~ http://investors.morningstar.com/ownership/shareholders-overview.html?t=CYNO®ion=USA&culture=en-us
Morningstar Transcripts~ http://www.morningstar.com/earnings/NoTranscript.aspx?t=CYNO®ion=USA
Morningstar Key Ratios ~ http://financials.morningstar.com/ratios/r.html?t=CYNO®ion=USA&culture=en-US
Morningstar Executive Compensation ~ http://insiders.morningstar.com/trading/executive-compensation.action?t=CYNO®ion=USA&culture=en-us
Morningstar Valuation ~ http://financials.morningstar.com/valuation/price-ratio.html?t=CYNO®ion=USA&culture=en-us


CCBN (Thompson Reuters) ~ http://ccbn.aol.com/company.asp?client=aol&ticker=CYNO


TradingMarkets ~ http://pr.tradingmarkets.com/?lid=leftPRbox&sym=CYNO


OTCBB ~ http://www.otcbb.com/asp/SiteSearch.asp?Criteria=CYNO&searcharea=e&image1.x=0&image1.y=0


Insidercow ~ http://www.insidercow.com/history/company.jsp?company=CYNO&B1=Search%21


Forbes News ~ http://search.forbes.com/search/find?tab=searchtabgeneraldark&MT=CYNO
Forbes Press Releases ~ http://search.forbes.com/search/find?&start=1&tab=searchtabgeneraldark&MT=CYNO&pub=businesswire,prnewswire&searchResults=pressRelease&tag=pr&premium=on
Forbes Web ~ http://search.forbes.com/search/web?MT=UNGS&start=1&max=10&searchResults=web&tag=web&sort=null


YouTube Symbol Search ~ http://www.youtube.com/results?search_query=CYNO


Buy-Ins ~ http://www.buyins.net/tools/symbol_stats.php?sym=CYNO


Quotemedia ~ http://www.quotemedia.com/results.php?qm_page=47556&qm_symbol=CYNO


Earnings Whispers ~ http://www.earningswhispers.com/stocks.asp?symbol=CYNO

Bloomberg Snapshot ~ http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=CYNO
Bloomberg People ~ http://investing.businessweek.com/research/stocks/people/people.asp?ticker=CYNO

Financial Times ~ http://markets.ft.com/Research/Markets/Tearsheets/Summary?s=CYNO

Investorpoint ~ http://www.investorpoint.com/ enter "CYNO" and click search.

Hotstocked ~ http://www.hotstocked.com/ enter "CYNO" and click search.

Raging Bull ~ http://ragingbull.quote.com/mboard/boards.cgi?board=CYNO

Hoovers ~ http://www.hoovers.com/search/company-search-results/100003765-1.html?type=company&term=CYNO

DD Machine ~ http://www.ddmachine.com/default.asp?m=stocktool_frame.asp?symbol=CYNO

SEC Form 4 ~ http://www.secform4.com/insider/showhistory.php?cik=CYNO

OTCBB Pulse ~ http://www.otcbbpulse.com/cgi-bin/pulsequote.cgi?symbol=CYNO

Failures To Deliver ~ http://failurestodeliver.com/default2.aspx enter "CYNO" and click search.

http://www.coordinatedlegal.com/SecretaryOfState.html

http://regsho.finra.org/regsho-Index.html

http://www.shortsqueeze.com/?symbol=CYNO&submit=Short+Quote%99



DTCC (PENSON/TDA) Check - (otc and pinks) - Note ~ I did not check for this chart blast. However, I try and help you to do so with the following links.
IHUB DTCC BOARD SEARCH #1 http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=CYNO
IHUB DTCC BOARD SEARCH #2: http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=14482&srchyr=2011&SearchStr=CYNO
Check those searches for recent CYNO mentions. If CYNO is showing up on older posts and not on new posts found in link below, The DTCC issues may have been addressed and fixed. Always call the broker if your security turns up on any DTCC/PENSON list.
http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18682&srchyr=2011&SearchStr=Complete+list
For a complete list see the pinned threads at the top here ---> http://tinyurl.com/TWO-OLD-FARTS



MACDlinks

~ Tuesday! $CYNO ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $CYNO ~ Earnings expected on Tuesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=CYNO&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=CYNO&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=CYNO
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=CYNO#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=CYNO+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=CYNO
Finviz: http://finviz.com/quote.ashx?t=CYNO
~ BusyStock: http://busystock.com/i.php?s=CYNO&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=CYNO >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

Nothing

what is going on?

Big earnings report tomorrow! GLTA the Longs!

Cyno is on the tip of a multi billion dollar field in Aesthetics it will be interesting to see how it fairs against other technologies in its field.